{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:50:00Z","timestamp":1791471000764,"version":"4.3.4"},"reference-count":31,"publisher":"Tsinghua University Press","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.26599\/1671-5411.2023.07.007","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T06:08:50Z","timestamp":1691647730000},"page":"527-537","source":"Crossref","is-referenced-by-count":13,"title":["Growth differentiation factor 15 predicts cardiovascular events in stable coronary artery disease"],"prefix":"10.26599","volume":"20","author":[{"given":"Juan","family":"WANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Na","family":"HAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-Sheng","family":"AI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yu","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Jing","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Rong","family":"XU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Bin","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Lei","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11138","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ejhf.431","article-title":"Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction","volume":"18","author":"MM Chan","year":"2016","unstructured":"MM Chan. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction. 2016, 18: 81-88.","journal-title":"Eur J Heart Fail"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1161\/CIRCULATIONAHA.118.034125","article-title":"Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation","volume":"138","author":"A Sharma","year":"2018","unstructured":"A Sharma. Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation. 2018, 138: 1666-1676.","journal-title":"Circulation"},{"key":"ref3","first-page":"908","article-title":"Biomarkers in the clinical management of patients with atrial fibrillation and heart failure","volume":"18","author":"I Koniari","year":"2021","unstructured":"I Koniari. Biomarkers in the clinical management of patients with atrial fibrillation and heart failure. 2021, 18: 908-951.","journal-title":"J Geriatr Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1161\/STROKEAHA.119.026410","article-title":"NfL (Neurofilament Light Chain) levels as a predictive marker for long-term outcome after ischemic stroke","volume":"50","author":"T Uphaus","year":"2019","unstructured":"T Uphaus. NfL (Neurofilament Light Chain) levels as a predictive marker for long-term outcome after ischemic stroke. 2019, 50: 3077-3084.","journal-title":"Stroke"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jchf.2022.05.013","article-title":"Pathophysiologic processes and novel biomarkers associated with congestion in heart failure","volume":"10","author":"P Pandhi","year":"2022","unstructured":"P Pandhi. Pathophysiologic processes and novel biomarkers associated with congestion in heart failure. 2022, 10: 623-632.","journal-title":"JACC Heart Failure"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.jacc.2022.08.767","article-title":"Biomarker-based prediction of recurrent ischemic events in patients with acute coronary syndromes","volume":"80","author":"G Batra","year":"2022","unstructured":"G Batra. Biomarker-based prediction of recurrent ischemic events in patients with acute coronary syndromes. 2022, 80: 1735-1747.","journal-title":"J Am Coll Cardio"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ahj.2013.09.013","article-title":"Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease","volume":"167","author":"DW Schopfer","year":"2014","unstructured":"DW Schopfer. Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease. 2014, 167: 186-192.e181.","journal-title":"Am Heart J"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e018217","DOI":"10.1093\/ehjci\/ehaa946.3018","article-title":"Impact of smoking status on growth differentiation factor 15 and mortality in patients with suspected or known coronary artery disease: The ANOX Study","volume":"9","author":"H Wada","year":"2020","unstructured":"H Wada. Impact of smoking status on growth differentiation factor 15 and mortality in patients with suspected or known coronary artery disease: The ANOX Study. 2020, 9: e018217.","journal-title":"J Am Heart Assoc"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1373\/clinchem.2016.260570","article-title":"Growth differentiation factor 15 predicts all-cause morbidity and mortality in stable coronary heart disease","volume":"63","author":"E Hagstr\u00f6m","year":"2017","unstructured":"E Hagstr\u00f6m. Growth differentiation factor 15 predicts all-cause morbidity and mortality in stable coronary heart disease. 2017, 63: 325-333.","journal-title":"Clin Chem"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.109.928846","article-title":"Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the valsartan heart failure trial","volume":"122","author":"IS Anand","year":"2010","unstructured":"IS Anand. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the valsartan heart failure trial. 2010, 122: 1387-1395.","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1161\/CIRCULATIONAHA.107.697714","article-title":"Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome","volume":"116","author":"KC Wollert","year":"2007","unstructured":"KC Wollert. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome. 2007, 116: 1540-1548.","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.atherosclerosis.2020.11.008","article-title":"Machine learning integration of circulating and imaging biomarkers for explainable patient-specific prediction of cardiac events: A prospective study","volume":"318","author":"BK Tamarappoo","year":"2021","unstructured":"BK Tamarappoo. Machine learning integration of circulating and imaging biomarkers for explainable patient-specific prediction of cardiac events: A prospective study. 2021, 318: 76-82.","journal-title":"Atherosclerosis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e021661","DOI":"10.1161\/JAHA.121.021661","article-title":"Association between circulating GDF-15 and cardio-renal outcomes and effect of canagliflozin: results from the CANVAS trial","volume":"10","author":"T Sen","year":"2021","unstructured":"T Sen. Association between circulating GDF-15 and cardio-renal outcomes and effect of canagliflozin: results from the CANVAS trial. 2021, 10: e021661.","journal-title":"J Am Heart Assoc"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/j.jacc.2017.03.580","article-title":"Multiple biomarkers in the context of conventional risk factors in patients with coronary artery disease","volume":"69","author":"J Wang","year":"2017","unstructured":"J Wang. Multiple biomarkers in the context of conventional risk factors in patients with coronary artery disease. 2017, 69: 2769-2770.","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e012826","DOI":"10.1161\/JAHA.119.012826","article-title":"Roles of growth differentiation factor 15 in atherosclerosis and coronary artery disease","volume":"8","author":"J Wang","year":"2019","unstructured":"J Wang. Roles of growth differentiation factor 15 in atherosclerosis and coronary artery disease. 2019, 8: e012826.","journal-title":"J Am Heart Assoc"},{"key":"ref16","first-page":"135","article-title":"Novel biomarkers for cardiovascular risk prediction","volume":"14","author":"J Wang","year":"2017","unstructured":"J Wang. Novel biomarkers for cardiovascular risk prediction. 2017, 14: 135-150.","journal-title":"J Geriatr Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1161\/CIRCULATIONAHA.111.061663","article-title":"Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR)","volume":"125","author":"P Damman","year":"2012","unstructured":"P Damman. Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR). 2012, 125: 568-576.","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/eurheartj\/ehv491","article-title":"Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study","volume":"37","author":"E Hagstr\u00f6m","year":"2016","unstructured":"E Hagstr\u00f6m. Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study. 2016, 37: 1325-1333.","journal-title":"Eur Heart J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00441-004-0986-3","article-title":"Involvement of growth differentiation factor-15\/macrophage inhibitory cytokine-1 (GDF-15\/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions","volume":"318","author":"D Schlittenhardt","year":"2004","unstructured":"D Schlittenhardt. Involvement of growth differentiation factor-15\/macrophage inhibitory cytokine-1 (GDF-15\/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. 2004, 318: 325-333.","journal-title":"Cell Tissue Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0140-6736(03)13976-1","article-title":"B-type natriuretic peptide in cardiovascular disease","volume":"362","author":"JA de Lemos","year":"2003","unstructured":"JA de Lemos. B-type natriuretic peptide in cardiovascular disease. 2003, 362: 316-322.","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/clinchem\/hvaa332","article-title":"Growth differentiation factor (GDF)-15 and cardiometabolic outcomes among older adults: the atherosclerosis risk in communities study","volume":"67","author":"JB Echouffo-Tcheugui","year":"2021","unstructured":"JB Echouffo-Tcheugui. Growth differentiation factor (GDF)-15 and cardiometabolic outcomes among older adults: the atherosclerosis risk in communities study. 2021, 67: 653-661.","journal-title":"Clin Chem"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00125-022-05678-6","article-title":"Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in community study","volume":"65","author":"JB Echouffo-Tcheugui","year":"2022","unstructured":"JB Echouffo-Tcheugui. Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in community study. 2022, 65: 955-963.","journal-title":"Diabetologia"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1373\/clinchem.2014.227116","article-title":"Biomarkers of cardiovascular stress and subclinical atherosclerosis in the community","volume":"60","author":"DM Gopal","year":"2014","unstructured":"DM Gopal. Biomarkers of cardiovascular stress and subclinical atherosclerosis in the community. 2014, 60: 1402-1408.","journal-title":"Clin Chem"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1054187","DOI":"10.3389\/fcvm.2023.1054187","article-title":"Prognostic value of growth differentiation factor-15 in patients with coronary artery disease: A meta-analysis and systematic review","volume":"10","author":"S Zhang","year":"2023","unstructured":"S Zhang. Prognostic value of growth differentiation factor-15 in patients with coronary artery disease: A meta-analysis and systematic review. 2023, 10: 1054187.","journal-title":"Front Cardiovasc Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jchf.2017.07.013","article-title":"Utility of growth differentiation factor-15, a marker of oxidative stress and inflammation, in chronic heart failure: insights from the HF-ACTION Study","volume":"5","author":"A Sharma","year":"2017","unstructured":"A Sharma. Utility of growth differentiation factor-15, a marker of oxidative stress and inflammation, in chronic heart failure: insights from the HF-ACTION Study. 2017, 5: 724-734.","journal-title":"JACC Heart Fail"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13046-018-0744-0","article-title":"GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1\/2 through the receptor ErbB2","volume":"37","author":"S Li","year":"2018","unstructured":"S Li. GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1\/2 through the receptor ErbB2. 2018, 37: 80.","journal-title":"J Exp Clin Cancer Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1172\/JCI91561","article-title":"NF-\u03baB regulates GDF-15 to suppress macrophage surveillance during early tumor development","volume":"127","author":"NM Ratnam","year":"2017","unstructured":"NM Ratnam. NF-\u03baB regulates GDF-15 to suppress macrophage surveillance during early tumor development. 2017, 127: 3796-3809.","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"H709","DOI":"10.1152\/ajpheart.00543.2012","article-title":"Growth differentiation factor 15 impairs aortic contractile and relaxing function through altered caveolar signaling of the endothelium","volume":"304","author":"M Mazagova","year":"2013","unstructured":"M Mazagova. Growth differentiation factor 15 impairs aortic contractile and relaxing function through altered caveolar signaling of the endothelium. 2013, 304: H709-H718.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1007\/s00125-019-4913-2","article-title":"The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomization study","volume":"62","author":"SL Au Yeung","year":"2019","unstructured":"SL Au Yeung. The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomization study. 2019, 62: 1638-1646.","journal-title":"Diabetologia"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1161\/CIRCGENETICS.108.824870","article-title":"Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study","volume":"2","author":"T Kempf","year":"2009","unstructured":"T Kempf. Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study. 2009, 2: 286-292.","journal-title":"Circ Cardiovasc Genet"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1161\/CIRCGENETICS.109.877456","article-title":"Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome","volume":"3","author":"KM Eggers","year":"2010","unstructured":"KM Eggers. Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome. 2010, 3: 88-96.","journal-title":"Circ Cardiovasc Genet"}],"container-title":["Journal of Geriatric Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T06:08:56Z","timestamp":1691647736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciopen.com\/article\/10.26599\/1671-5411.2023.07.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"URL":"https:\/\/doi.org\/10.26599\/1671-5411.2023.07.007","relation":{},"ISSN":["1671-5411"],"issn-type":[{"value":"1671-5411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]}}}